Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size

Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Elana Rosencrantz, Argosy University
ClinicalTrials.gov Identifier:
NCT01263067
First received: December 15, 2010
Last updated: January 13, 2015
Last verified: January 2015
History of Changes
  Purpose

The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma


Condition Intervention
Posttraumatic Stress Disorder
 Behavioral: Lifespan Integration Therapy
Behavioral: Lifespan Integration- Control

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Lifespan Integration Therapy for Posttraumatic Stress Disorder of Adults Involved in an Auto Accident

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Argosy University:

Primary Outcome Measures:
  • Clinicians Administered PTSD Scale [ Time Frame: following the final treatment session (average of 6 weeks from treatment start date) ] [ Designated as safety issue: No ]
    Participants will be assessed with the CAPS following the final treatment session (up to 5 treatment sessions).


Secondary Outcome Measures:
  • Personality Assessment Inventory [ Time Frame: following the final treatment session (average of 6 weeks from treatment start date) ] [ Designated as safety issue: No ]
Enrollment: 6
Study Start Date: October 2010
Study Completion Date: January 2012
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lifespan Integration Therapy (LI) Behavioral: Lifespan Integration Therapy
LI treatment guides the client to imaginally visit past memories, and then leads her or him forward through time to the present using a concept referred to as the time line. Beginning with the individual's memories from the traumatic experience, the time line first follows memories from the days and weeks after the trauma, then season by season to the present, and is reviewed in ongoing sessions as increasing details of the traumatic event are uncovered.
Active Comparator: Waitlist Control- Lifespan Integration Behavioral: Lifespan Integration- Control
Participants selected for the control group will be treated 4 weeks following initial contact. Treatment is the same as for the Experimental Group.

Detailed Description:

Studies estimate a substantial proportion of MVA survivors, ranging from 9.4% to 59.9%, will develop PTSD following an accident (Blanchard & Hickling, 2004). Based on conservative estimates, past research, indicates that MVA-related PTSD may affect 2.5 to 7 million persons in the United States (Blanchard & Hickling). Furthermore, two seminal epidemiological studies (Kessler et al., 1995; Norris, 1992) that focused on causes of adult PTSD identified MVAs as the most frequent trauma resulting in PTSD. For these reasons, MVA-resultant PTSD represents a significant public health problem that needs not only to be thoroughly understood, but addressed with successful mental health treatment options (Beck & Coffey, 2007; Blanchard & Hickling, 1997, 2004; Bryant et al., 1998; Taylor et al., 1999; Taylor et al., 2001). Although there is empirical literature on the treatment of PTSD following an MVA, additional efficacious and rigorously conducted studies with statistical underpinnings are required to determine the results that can be expected from alternative models of care (Beck & Coffey; Blanchard & Hickling, 1997, 2004).

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Involved in or witnessed a car accident at least 6 months ago.
  • PTSD or distress or impairment in important areas of functioning following the car accident

Exclusion Criteria:

  • moderate or severe head injury
  • current mental health treatment for the MVA-related problem
  • severe chronic pre-injury mental health problems
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01263067

Locations
United States, Washington
Argosy University Seattle
Seattle, Washington, United States, 98103
Sponsors and Collaborators
Argosy University
Investigators
Study Chair: Frances Parks, PhD Argosy University Seattle
  More Information

Additional Information:
Related Info  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Elana Rosencrantz, Student, Argosy University
ClinicalTrials.gov Identifier: NCT01263067     History of Changes
Other Study ID Numbers: 2010-10
Study First Received: December 15, 2010
Last Updated: January 13, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Argosy University:
Posttraumatic Stress Disorder
PTSD
Car Accident
Auto Accident
Lifespan Integration

Additional relevant MeSH terms:
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on March 03, 2015